Literature DB >> 8446326

Nasal secretions in ocular surgery under general and local anesthesia.

F Nagle1, R L Cooper.   

Abstract

To investigate the etiology of nasopharyngeal secretion reflux under anesthesia, which could contaminate the conjunctiva, we photographed, after preoperative nasal instillation of fluorescein, the faces of 224 consecutive patients having cataract surgery under general (n = 78) and local (n = 146) anesthesia. In 10 patients, extension of the neck and facial contour caused fluid to drain from the nose directly into the conjunctival cul-de-sac. Nine of the 78 patients under general anesthesia had nasal secretions on the face at the end of surgery, usually due to leaking around the endotracheal tube. Adjusting head posture by moderate neck flexion and taking care to prevent leakage around the endotracheal tube, together with antiseptic preparation of the nose, may prevent contamination of the operative field by nasal secretions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446326

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  3 in total

1.  Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment.

Authors:  Terry J Alexandrou; Seenu M Hariprasad; Joseph Benevento; Michael P Rubin; Michael Saidel; Susan Ksiazek; Kenneth Thompson; Sue Boonlayangoor; William F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  2006

2.  Efficacy of sevoflurane as an adjuvant to propofol-based total intravenous anesthesia for attenuating secretions in ocular surgery.

Authors:  Hou-Chuan Lai; Yun-Hsiang Chang; Ren-Chih Huang; Nan-Kai Hung; Chueng-He Lu; Jou-Hsiu Chen; Zhi-Fu Wu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Relationship between anesthesia and postoperative endophthalmitis: A retrospective study.

Authors:  Hou-Chuan Lai; Wei-Cheng Tseng; Shu-I Pao; Chih-Shung Wong; Ren-Chih Huang; Wei-Hung Chan; Zhi-Fu Wu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.